Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

Also called NCT06658197

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 850 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06658197
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06658197. Randomized; single masking; primary purpose treatment. Start 2025-12-25 (actual); primary completion 2026-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
Acronym
TNK-LVO
Condition
Stroke, Ischemic
Condition
Stroke, Acute
Condition
Thrombosis, Brain
Condition
Drug Effect
Intervention (Drug)
Tenecteplase
Intervention (Drug)
Alteplase
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct06658197
Content hash
baf1be5582919acf7abfa218c12a7e5fcb31bfbbff622be7473c28c4463a1f07